ABT logo

Abbott Laboratories (ABT) Cash From Operations

Annual CFO

$7.26 B
-$2.32 B-24.21%

31 December 2023

ABT Cash From Operations Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFO

$2.71 B
+$745.00 M+38.01%

30 September 2024

ABT Quarterly CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFO

$8.73 B
+$828.00 M+10.48%

30 September 2024

ABT TTM CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ABT Cash From Operations Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-24.2%+44.1%+33.3%
3 y3 years-8.1%+0.1%-22.5%
5 y5 years+15.3%+38.9%+59.1%

ABT Cash From Operations High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-31.1%at low-11.8%+163.9%-22.5%+33.3%
5 y5 years-31.1%+18.3%-28.8%+278.3%-22.5%+59.1%
alltimeall time-31.1%+656.4%-28.8%+3008.6%-22.5%+3912.9%

Abbott Laboratories Cash From Operations History

DateAnnualQuarterlyTTM
Sept 2024
-
$2.71 B(+38.0%)
$8.73 B(+10.5%)
June 2024
-
$1.96 B(+91.2%)
$7.90 B(+10.6%)
Mar 2024
-
$1.02 B(-66.3%)
$7.14 B(-1.6%)
Dec 2023
$7.26 B(-24.2%)
$3.04 B(+61.9%)
$7.26 B(+10.9%)
Sept 2023
-
$1.88 B(+56.0%)
$6.55 B(-12.1%)
June 2023
-
$1.20 B(+5.2%)
$7.45 B(-13.9%)
Mar 2023
-
$1.14 B(-50.9%)
$8.66 B(-9.6%)
Dec 2022
$9.58 B(-9.0%)
$2.33 B(-16.3%)
$9.58 B(-7.2%)
Sept 2022
-
$2.78 B(+15.4%)
$10.32 B(+0.8%)
June 2022
-
$2.41 B(+16.7%)
$10.24 B(+2.8%)
Mar 2022
-
$2.06 B(-32.7%)
$9.96 B(-5.4%)
Dec 2021
$10.53 B(+33.3%)
$3.07 B(+13.6%)
$10.53 B(-6.5%)
Sept 2021
-
$2.70 B(+26.9%)
$11.26 B(+6.0%)
June 2021
-
$2.13 B(-19.3%)
$10.63 B(+8.2%)
Mar 2021
-
$2.64 B(-30.6%)
$9.82 B(+24.3%)
Dec 2020
$7.90 B(+28.8%)
$3.80 B(+83.8%)
$7.90 B(+21.2%)
Sept 2020
-
$2.07 B(+56.3%)
$6.52 B(+1.8%)
June 2020
-
$1.32 B(+84.9%)
$6.40 B(+4.3%)
Mar 2020
-
$715.00 M(-70.4%)
$6.14 B(+0.0%)
Dec 2019
$6.14 B(-2.6%)
$2.42 B(+24.0%)
$6.14 B(+11.9%)
Sept 2019
-
$1.95 B(+83.8%)
$5.49 B(-4.1%)
June 2019
-
$1.06 B(+48.9%)
$5.72 B(-3.1%)
Mar 2019
-
$712.00 M(-59.7%)
$5.90 B(-6.3%)
Dec 2018
$6.30 B(+13.1%)
$1.76 B(-19.1%)
$6.30 B(+2.0%)
Sept 2018
-
$2.18 B(+75.5%)
$6.17 B(+3.0%)
June 2018
-
$1.24 B(+12.3%)
$6.00 B(-1.8%)
Mar 2018
-
$1.11 B(-32.4%)
$6.10 B(+9.6%)
Dec 2017
$5.57 B(+73.9%)
$1.64 B(-18.2%)
$5.57 B(+9.2%)
Sept 2017
-
$2.00 B(+48.4%)
$5.10 B(+18.3%)
June 2017
-
$1.35 B(+135.4%)
$4.31 B(+11.4%)
Mar 2017
-
$574.00 M(-50.9%)
$3.87 B(+20.8%)
Dec 2016
$3.20 B(+8.0%)
$1.17 B(-3.9%)
$3.20 B(+12.0%)
Sept 2016
-
$1.22 B(+33.9%)
$2.86 B(+0.8%)
June 2016
-
$909.00 M(-1077.4%)
$2.84 B(-1.1%)
Mar 2016
-
-$93.00 M(-111.2%)
$2.87 B(-3.2%)
Dec 2015
$2.97 B(-19.3%)
$828.00 M(-30.7%)
$2.97 B(-12.1%)
Sept 2015
-
$1.20 B(+27.0%)
$3.38 B(-0.2%)
June 2015
-
$941.00 M(>+9900.0%)
$3.38 B(+1.2%)
Mar 2015
-
$2.00 M(-99.8%)
$3.34 B(-9.1%)
Dec 2014
$3.67 B(+10.6%)
$1.24 B(+3.1%)
$3.67 B(-9.5%)
Sept 2014
-
$1.20 B(+33.4%)
$4.06 B(+20.1%)
June 2014
-
$900.00 M(+167.9%)
$3.38 B(+5.7%)
Mar 2014
-
$336.00 M(-79.3%)
$3.20 B(-3.7%)
Dec 2013
$3.32 B(-64.3%)
$1.63 B(+211.3%)
$3.32 B(+3.8%)
Sept 2013
-
$522.00 M(-27.2%)
$3.20 B(-48.4%)
June 2013
-
$717.00 M(+55.9%)
$6.20 B(-17.9%)
Mar 2013
-
$460.00 M(-69.4%)
$7.55 B(-18.9%)
Dec 2012
$9.31 B(+3.8%)
$1.50 B(-57.3%)
$9.31 B(+1.1%)
Sept 2012
-
$3.52 B(+70.3%)
$9.21 B(+5.3%)
June 2012
-
$2.07 B(-7.1%)
$8.75 B(-4.8%)
Mar 2012
-
$2.22 B(+58.8%)
$9.18 B(+2.4%)
Dec 2011
$8.97 B(+2.7%)
$1.40 B(-54.1%)
$8.97 B(-9.3%)
Sept 2011
-
$3.05 B(+22.0%)
$9.89 B(+5.4%)
June 2011
-
$2.50 B(+24.5%)
$9.38 B(+1.7%)
Mar 2011
-
$2.01 B(-13.2%)
$9.22 B(+5.6%)
Dec 2010
$8.74 B(+20.1%)
$2.32 B(-9.1%)
$8.74 B(+5.9%)
Sept 2010
-
$2.55 B(+8.5%)
$8.25 B(-5.5%)
June 2010
-
$2.35 B(+54.2%)
$8.73 B(+7.8%)
Mar 2010
-
$1.52 B(-16.9%)
$8.10 B(+11.3%)
Dec 2009
$7.28 B(+4.0%)
$1.83 B(-39.5%)
$7.28 B(+9.0%)
Sept 2009
-
$3.03 B(+76.8%)
$6.68 B(+5.2%)
June 2009
-
$1.71 B(+145.3%)
$6.34 B(-0.7%)
Mar 2009
-
$698.72 M(-43.3%)
$6.39 B(-8.7%)
Dec 2008
$6.99 B(+34.9%)
$1.23 B(-54.3%)
$6.99 B(+2.7%)
Sept 2008
-
$2.70 B(+53.5%)
$6.81 B(+20.5%)
June 2008
-
$1.76 B(+34.7%)
$5.65 B(+4.0%)
Mar 2008
-
$1.31 B(+24.3%)
$5.43 B(+4.8%)
Dec 2007
$5.18 B
$1.05 B(-31.7%)
$5.18 B(-4.4%)
Sept 2007
-
$1.54 B(-0.1%)
$5.42 B(+4.9%)
June 2007
-
$1.54 B(+45.7%)
$5.17 B(-0.6%)
DateAnnualQuarterlyTTM
Mar 2007
-
$1.06 B(-18.0%)
$5.20 B(-2.4%)
Dec 2006
$5.33 B(+3.0%)
$1.29 B(+0.3%)
$5.33 B(-1.2%)
Sept 2006
-
$1.28 B(-18.3%)
$5.39 B(-2.5%)
June 2006
-
$1.57 B(+32.9%)
$5.53 B(-5.0%)
Mar 2006
-
$1.18 B(-12.4%)
$5.82 B(+12.6%)
Dec 2005
$5.17 B(+15.8%)
$1.35 B(-5.2%)
$5.17 B(+10.4%)
Sept 2005
-
$1.42 B(-23.6%)
$4.68 B(+13.6%)
June 2005
-
$1.86 B(+249.3%)
$4.13 B(+11.4%)
Mar 2005
-
$533.73 M(-38.1%)
$3.70 B(-17.1%)
Dec 2004
$4.47 B(+25.7%)
$861.69 M(-0.5%)
$4.47 B(+6.8%)
Sept 2004
-
$865.78 M(-40.0%)
$4.18 B(-3.9%)
June 2004
-
$1.44 B(+11.3%)
$4.35 B(+11.5%)
Mar 2004
-
$1.30 B(+123.9%)
$3.91 B(+9.9%)
Dec 2003
$3.55 B(-11.0%)
$578.97 M(-44.1%)
$3.55 B(-10.8%)
Sept 2003
-
$1.04 B(+4.0%)
$3.98 B(+3.5%)
June 2003
-
$995.61 M(+5.6%)
$3.85 B(+2.0%)
Mar 2003
-
$943.02 M(-6.5%)
$3.77 B(-5.5%)
Dec 2002
$3.99 B(+11.9%)
$1.01 B(+12.0%)
$3.99 B(+3.1%)
Sept 2002
-
$900.93 M(-2.0%)
$3.87 B(-6.8%)
June 2002
-
$918.87 M(-21.0%)
$4.15 B(+9.0%)
Mar 2002
-
$1.16 B(+31.1%)
$3.81 B(+6.9%)
Dec 2001
$3.57 B(+15.1%)
$887.39 M(-25.1%)
$3.57 B(+3.3%)
Sept 2001
-
$1.18 B(+105.4%)
$3.45 B(+17.2%)
June 2001
-
$576.51 M(-37.2%)
$2.95 B(-19.0%)
Mar 2001
-
$918.57 M(+18.6%)
$3.64 B(+17.4%)
Dec 2000
$3.10 B(+5.5%)
$774.18 M(+14.2%)
$3.10 B(+16.8%)
Sept 2000
-
$677.88 M(-46.5%)
$2.65 B(-10.7%)
June 2000
-
$1.27 B(+233.6%)
$2.97 B(+19.0%)
Mar 2000
-
$379.96 M(+15.7%)
$2.50 B(-15.0%)
Dec 1999
$2.94 B(+5.7%)
$328.46 M(-67.0%)
$2.94 B(-5.9%)
Sept 1999
-
$995.94 M(+25.6%)
$3.12 B(+15.8%)
June 1999
-
$792.96 M(-3.3%)
$2.70 B(-0.9%)
Mar 1999
-
$820.14 M(+60.2%)
$2.72 B(-2.2%)
Dec 1998
$2.78 B(+4.5%)
$512.10 M(-10.2%)
$2.78 B(-4.7%)
Sept 1998
-
$570.46 M(-30.1%)
$2.92 B(-2.5%)
June 1998
-
$816.24 M(-7.4%)
$2.99 B(+8.6%)
Mar 1998
-
$881.40 M(+35.6%)
$2.76 B(+3.6%)
Dec 1997
$2.66 B(+11.7%)
$649.90 M(+0.6%)
$2.66 B(+3.1%)
Sept 1997
-
$646.29 M(+11.6%)
$2.58 B(+0.5%)
June 1997
-
$579.28 M(-26.2%)
$2.57 B(+3.4%)
Mar 1997
-
$784.63 M(+37.5%)
$2.48 B(+4.2%)
Dec 1996
$2.38 B(+21.2%)
$570.56 M(-9.8%)
$2.38 B(+7.2%)
Sept 1996
-
$632.54 M(+27.8%)
$2.22 B(+5.4%)
June 1996
-
$494.80 M(-27.7%)
$2.11 B(-1.5%)
Mar 1996
-
$684.20 M(+66.4%)
$2.14 B(+8.9%)
Dec 1995
$1.97 B(-11.1%)
$411.18 M(-20.8%)
$1.97 B(-8.4%)
Sept 1995
-
$519.18 M(-1.5%)
$2.15 B(-3.6%)
June 1995
-
$526.89 M(+3.7%)
$2.23 B(+2.5%)
Mar 1995
-
$508.33 M(-14.1%)
$2.17 B(-1.7%)
Dec 1994
$2.21 B(+19.8%)
$591.69 M(-1.5%)
$2.21 B(+5.7%)
Sept 1994
-
$600.46 M(+26.9%)
$2.09 B(+1.3%)
June 1994
-
$473.14 M(-13.5%)
$2.06 B(+5.5%)
Mar 1994
-
$546.85 M(+15.8%)
$1.96 B(+6.0%)
Dec 1993
$1.85 B(+33.0%)
$472.11 M(-17.6%)
$1.85 B(-1.9%)
Sept 1993
-
$572.70 M(+56.4%)
$1.88 B(+19.3%)
June 1993
-
$366.10 M(-16.0%)
$1.58 B(+1.4%)
Mar 1993
-
$436.00 M(-14.2%)
$1.56 B(+12.1%)
Dec 1992
$1.39 B(-4.4%)
$508.40 M(+90.1%)
$1.39 B(+7.3%)
Sept 1992
-
$267.50 M(-22.4%)
$1.29 B(-9.8%)
June 1992
-
$344.60 M(+28.4%)
$1.44 B(-2.8%)
Mar 1992
-
$268.30 M(-35.2%)
$1.48 B(+1.6%)
Dec 1991
$1.45 B(+21.0%)
$414.20 M(+1.4%)
$1.45 B(+2.8%)
Sept 1991
-
$408.30 M(+6.0%)
$1.41 B(+3.5%)
June 1991
-
$385.30 M(+57.0%)
$1.37 B(+11.2%)
Mar 1991
-
$245.40 M(-34.5%)
$1.23 B(+2.3%)
Dec 1990
$1.20 B(+25.1%)
$374.90 M(+4.0%)
$1.20 B(+45.4%)
Sept 1990
-
$360.50 M(+45.4%)
$826.00 M(+77.4%)
June 1990
-
$248.00 M(+14.0%)
$465.50 M(+114.0%)
Mar 1990
-
$217.50 M
$217.50 M
Dec 1989
$959.90 M
-
-

FAQ

  • What is Abbott Laboratories annual cash flow from operations?
  • What is the all time high annual CFO for Abbott Laboratories?
  • What is Abbott Laboratories annual CFO year-on-year change?
  • What is Abbott Laboratories quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Abbott Laboratories?
  • What is Abbott Laboratories quarterly CFO year-on-year change?
  • What is Abbott Laboratories TTM cash flow from operations?
  • What is the all time high TTM CFO for Abbott Laboratories?
  • What is Abbott Laboratories TTM CFO year-on-year change?

What is Abbott Laboratories annual cash flow from operations?

The current annual CFO of ABT is $7.26 B

What is the all time high annual CFO for Abbott Laboratories?

Abbott Laboratories all-time high annual cash flow from operations is $10.53 B

What is Abbott Laboratories annual CFO year-on-year change?

Over the past year, ABT annual cash flow from operations has changed by -$2.32 B (-24.21%)

What is Abbott Laboratories quarterly cash flow from operations?

The current quarterly CFO of ABT is $2.71 B

What is the all time high quarterly CFO for Abbott Laboratories?

Abbott Laboratories all-time high quarterly cash flow from operations is $3.80 B

What is Abbott Laboratories quarterly CFO year-on-year change?

Over the past year, ABT quarterly cash flow from operations has changed by +$828.00 M (+44.11%)

What is Abbott Laboratories TTM cash flow from operations?

The current TTM CFO of ABT is $8.73 B

What is the all time high TTM CFO for Abbott Laboratories?

Abbott Laboratories all-time high TTM cash flow from operations is $11.26 B

What is Abbott Laboratories TTM CFO year-on-year change?

Over the past year, ABT TTM cash flow from operations has changed by +$2.18 B (+33.27%)